Johnson & Johnson Share Price Buenos Aires S.E.
Equities
DJNJ3D
ARDEUT112687
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,153 ARS | -.--% | -1.28% | +0.26% |
Sales 2024 * | 88.37B 78,120B 7,039B | Sales 2025 * | 90.78B 80,250B 7,231B | Capitalization | 364B 321,721B 28,991B |
---|---|---|---|---|---|
Net income 2024 * | 22.04B 19,482B 1,756B | Net income 2025 * | 23.09B 20,413B 1,839B | EV / Sales 2024 * | 4.04 x |
Net cash position 2024 * | 7B 6,185B 557B | Net cash position 2025 * | 21.07B 18,630B 1,679B | EV / Sales 2025 * | 3.78 x |
P/E ratio 2024 * |
16.8
x | P/E ratio 2025 * |
15.9
x | Employees | 131,900 |
Yield 2024 * |
3.19% | Yield 2025 * |
3.33% | Free-Float | 77.07% |
Latest transcript on Johnson & Johnson
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 31/12/88 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 31/12/97 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 04/11/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 24/04/19 |
D. Davis
BRD | Director/Board Member | 72 | 18/06/14 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 21/10/09 |
Date | Price | Change | Volume |
---|---|---|---|
10/05/24 | 1,210 | +0.41% | 3 |
07/05/24 | 1,205 | +0.42% | 9 |
End-of-day quote Buenos Aires S.E., April 25, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+29.98% | 682B | |
+30.34% | 586B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.21% | 240B | |
+9.66% | 209B | |
-6.83% | 203B | |
+7.09% | 165B | |
-1.22% | 161B |
- Stock Market
- Equities
- JNJ Stock
- DJNJ3D Stock